First generic HIV prevention injection gets FDA tentative approval

The FDA has granted tentative approval to Dr. Reddy’s Laboratories for the first generic version of lenacapavir, the twice-yearly injection for HIV prevention, according to a Nov. 2 news release from the Clinton Health Access Initiative, one of the partners that supported its development. The decision came 16 months after the FDA approved Gilead Sciences’ […] The post First generic HIV prevention injection gets FDA tentative approval appeared first on Becker's Hospital Review | Health...